| 1/4 | US=50 / Câncer Neeb A, Sleeman JP. Tumor lymphangiogenesis: what we know and don't know. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 93-104. ISBN 978-1-60327-086-1. LINFANGIOGENESE TUMOR; METASTASE; LINFANGIOGENESE; LINFONODO; VEGFR-3; VEGF-C; VEGF-D |
| 2/4 | US=50 / Câncer Detmar M. Tumor and lymph node lymphangiogenesis. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 255-61. ISBN 978-1-60327-086-1. TUMOR; LINFANGIOGENESE LINFONODO; CANCER; LINFANGIOGENESE; METASTASE LINFATICA; VEGF-A; VEGF-C; VEGFR-3; ANGIOGENESE |
| 3/4 | US=69 / Câncer Stewart DJ. Targeted therapy in non-small cell lung cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 125-56. ISBN 978-1-60327-423-4. TERAPIA-ALVO; NAO-PEQUENAS DE CANCER DE PULMAO DE CELULAS; EGFR; ERLOTINIB; GEFITINIB; VEGFR |
| 4/4 | US=472 / Tese/FAP Barreno LRQ. Fatores prognósticos em pacientes com mais de 45 anos portadores de carcinoma bem diferenciado de tireóide. [Prognostic factors in patients over 45 years old, with well differentiated thyroid carcinoma]. São Paulo, 2013. 97 p. Dissertação(Mestrado)-Fundação Antônio Prudente. Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2013/LuisRQuiroa/LuisRQuiroa.pdf NEOPLASIAS; NODULO DA GLANDULA TIREOIDE; INCIDENCIA; MUTACAO; RECEPTOR 1 DE FATORES DE CRESCIMENTO DO ENDOTELIO VASCULAR; VEGFR; MUTACAO DE BRAF |